{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:51:19Z","timestamp":1768315879883,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Wu Tai Shan Hospital of Yangzhou"},{"name":"Social Development Project by Science and Technology Bureau of Yangzhou City","award":["YZ2014215, YZ2014025"],"award-info":[{"award-number":["YZ2014215, YZ2014025"]}]},{"name":"Medical Scientific Research Project of Jiangsu Provincial Commission of Health and Family Planning","award":["Z201522"],"award-info":[{"award-number":["Z201522"]}]},{"name":"Scientific Research Foundation of Jiangsu Provincial 333 Project","award":["BRA2015541, BRA2016555"],"award-info":[{"award-number":["BRA2015541, BRA2016555"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.euroneuro.2018.03.007","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T12:58:31Z","timestamp":1522155511000},"page":"603-609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Baseline serum vascular endothelial growth factor levels predict treatment response to antipsychotic medication in patients with schizophrenia"],"prefix":"10.1016","volume":"28","author":[{"given":"Wenhuan","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongqiong","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Sha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2018.03.007_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eurpsy.2016.05.010","article-title":"Inflammatory, cardio-metabolic and diabetic profiling of chronic schizophrenia","volume":"39","author":"Balotsev","year":"2016","journal-title":"Eur. Psychiatry: J. Assoc. Eur. Psychiatr."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.psyneuen.2015.07.002","article-title":"Peripheral vascular endothelial growth factor as a novel depression biomarker: a meta-analysis","volume":"62","author":"Carvalho","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.euroneuro.2018.03.007_bib3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/15622975.2015.1117655","article-title":"Vascular endothelial growth factor: potential predictor of treatment response in major depression","volume":"18","author":"Clark-Raymond","year":"2016","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.03.007_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jpsychires.2014.08.005","article-title":"Vascular endothelial growth factor: a potential diagnostic biomarker for major depression","volume":"59","author":"Clark-Raymond","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbi.2012.06.010","article-title":"Serum and gene expression profile of cytokines in first-episode psychosis","volume":"31","author":"Di Nicola","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.eurpsy.2004.06.020","article-title":"Neurotrophic factors and the pathophysiology of schizophrenic psychoses","volume":"19","author":"Durany","year":"2004","journal-title":"Eur. Psychiatry: J. Assoc. Eur. Psychiatr."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib7","first-page":"1409","article-title":"Depression and BMI influences the serum vascular endothelial growth factor level","volume":"17","author":"Elfving","year":"2014","journal-title":"Int. J. Neuropsychopharmacol.\/Off. Sci. J. Coll. Int. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drugalcdep.2015.04.022","article-title":"Serum level of vascular endothelial growth factor decreased in chronic ketamine abusers","volume":"152","author":"Fan","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12916-017-0849-x","article-title":"The new field of 'precision psychiatry'","volume":"15","author":"Fernandes","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.bbr.2011.04.022","article-title":"Role of vascular endothelial growth factor in adult hippocampal neurogenesis: implications for the pathophysiology and treatment of depression","volume":"227","author":"Fournier","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.schres.2009.06.005","article-title":"Decreased VEGF mRNA expression in the dorsolateral prefrontal cortex of schizophrenia subjects","volume":"115","author":"Fulzele","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pnpbp.2013.04.011","article-title":"Vascular endothelial growth factor gene (VEGFA) polymorphisms may serve as prognostic factors for recurrent depressive disorder development","volume":"45","author":"Galecki","year":"2013","journal-title":"Progress. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.03.007_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/wps.20026","article-title":"Future perspectives on the treatment of cognitive deficits and negative symptoms in schizophrenia","volume":"12","author":"Goff","year":"2013","journal-title":"World Psychiatry: Off. J. World Psychiatr. Assoc."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.schres.2015.08.027","article-title":"Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index","volume":"169","author":"Haring","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jpsychires.2016.07.018","article-title":"Decreased VEGFR2 expression and increased phosphorylated Akt1 in the prefrontal cortex of individuals with schizophrenia","volume":"82","author":"Hino","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/jamaneurol.2014.4761","article-title":"The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease","volume":"72","author":"Hohman","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib17","doi-asserted-by":"crossref","first-page":"e20198","DOI":"10.1371\/journal.pone.0020198","article-title":"Long-term continuous corticosterone treatment decreases VEGF receptor-2 expression in frontal cortex","volume":"6","author":"Howell","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.euroneuro.2018.03.007_bib18","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1038\/tp.2012.123","article-title":"Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters","volume":"2","author":"Isung","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.03.007_bib19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3109\/15622975.2011.624549","article-title":"Low plasma vascular endothelial growth factor (VEGF) associated with completed suicide","volume":"13","author":"Isung","year":"2012","journal-title":"World J. Biol. Psychiatry: Off. J. World Fed. Soc. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.03.007_bib20","doi-asserted-by":"crossref","first-page":"742612","DOI":"10.1155\/2015\/742612","article-title":"The effect of depression on serum VEGF level in Alzheimer's disease","volume":"2015","author":"Jung","year":"2015","journal-title":"Dis. Markers"},{"key":"10.1016\/j.euroneuro.2018.03.007_bib21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neuroscience.2012.01.023","article-title":"Regular exercise cures depression-like behavior via VEGF-Flk-1 signaling in chronically stressed mice","volume":"207","author":"Kiuchi","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2018.03.007_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.psychres.2015.04.020","article-title":"Alterations in plasma vascular endothelial growth factor levels in patients with schizophrenia before and after treatment","volume":"228","author":"Lee","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib23","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/sj.npp.1301325","article-title":"Defining 'response' in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs","volume":"32","author":"Leucht","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2018.03.007_bib24","first-page":"7","article-title":"Definitions of response and remission in schizophrenia: recommendations for their use and their presentation","volume":"124","author":"Leucht","year":"2011","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib25","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1073\/pnas.1007640108","article-title":"Reversible modulations of neuronal plasticity by VEGF","volume":"108","author":"Licht","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2018.03.007_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.schres.2015.12.001","article-title":"Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: a preliminary study","volume":"170","author":"Lizano","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuroimage.2015.10.084","article-title":"Relationships of peripheral IGF-1, VEGF and BDNF levels to exercise-related changes in memory, hippocampal perfusion and volumes in older adults","volume":"131","author":"Maass","year":"2016","journal-title":"NeuroImage"},{"key":"10.1016\/j.euroneuro.2018.03.007_bib28","first-page":"1218","article-title":"Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades","volume":"15","author":"Matsuzaki","year":"2001","journal-title":"Faseb J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/wps.20144","article-title":"Biomarkers and clinical staging in psychiatry","volume":"13","author":"McGorry","year":"2014","journal-title":"World Psychiatry: Off. J. World Psychiatr. Assoc."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/acps.12187","article-title":"Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy","volume":"129","author":"Minelli","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib31","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.pnpbp.2011.04.013","article-title":"Vascular endothelial growth factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients","volume":"35","author":"Minelli","year":"2011","journal-title":"Progress. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.03.007_bib32","first-page":"719395","article-title":"Vascular endothelial growth factor and brain-derived neurotrophic factor in quetiapine treated first-episode psychosis","volume":"2014","author":"Murphy","year":"2014","journal-title":"Schizophr. Res. Treat."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib33","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00018-013-1281-9","article-title":"Vascular growth factors in neuropsychiatry","volume":"70","author":"Newton","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2011.05.005","article-title":"Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action","volume":"46","author":"Nowacka","year":"2012","journal-title":"Neuropeptides"},{"key":"10.1016\/j.euroneuro.2018.03.007_bib35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","article-title":"Schizophrenia","volume":"388","author":"Owen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2018.03.007_bib36","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/mp.2015.96","article-title":"Association of serum VEGF levels with prefrontal cortex volume in schizophrenia","volume":"21","author":"Pillai","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.03.007_bib37","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1152\/physrev.00031.2008","article-title":"Role and therapeutic potential of VEGF in the nervous system","volume":"89","author":"Ruiz","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jad.2016.02.067","article-title":"Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: a comprehensive review of human studies","volume":"197","author":"Sharma","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2015.03.022","article-title":"VEGF can protect against blood brain barrier dysfunction, dendritic spine loss and spatial memory impairment in an experimental model of diabetes","volume":"78","author":"Taylor","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib40","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.euroneuro.2015.06.001","article-title":"Increased levels of vascular endothelial growth factor in patients with major depressive disorder: a meta-analysis","volume":"25","author":"Tseng","year":"2015","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/10520295.2014.946968","article-title":"Effects of voluntary and involuntary exercise on cognitive functions, and VEGF and BDNF levels in adolescent rats","volume":"90","author":"Uysal","year":"2015","journal-title":"Biotech. Histochem.: Off. Publ. Biol. Stain Comm."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib42","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.archger.2014.04.011","article-title":"Physical exercise and vascular endothelial growth factor (VEGF) in elderly: a systematic review","volume":"59","author":"Vital","year":"2014","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.euroneuro.2018.03.007_bib43","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.psychres.2016.11.001","article-title":"Atypical antipsychotic treatment increases glial cell line-derived neurotrophic factor serum levels in drug-free schizophrenic patients along with improvement of psychotic symptoms and therapeutic effects","volume":"246","author":"Xiao","year":"2016","journal-title":"Psychiatry Res."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X18300701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X18300701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T21:36:17Z","timestamp":1577136977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X18300701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0924977X18300701"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2018.03.007","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baseline serum vascular endothelial growth factor levels predict treatment response to antipsychotic medication in patients with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2018.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}